StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Wednesday. The firm issued a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on the company. HC Wainwright decreased their price target on Alimera Sciences from $9.00 […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note published on Tuesday. The firm issued a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on ALIM. Alliance Global Partners upgraded shares of Alimera Sciences from a neutral rating […]
StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Tuesday. Separately, TheStreet raised shares of ADMA Biologics from a d rating to a c- rating in a research report on Friday, May 19th. ADMA Biologics Stock Down 2.8 % Shares […]
Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on ALIM. Alliance Global Partners raised shares of Alimera Sciences from a “neutral” rating […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. Craig Hallum decreased their target price on shares of Alimera Sciences from […]